2658-6533Research Results in Biomedicine2658-653310.18413/2313-8955-2016-2-3-41-48772Archive categoriesMARKETING ANALYSIS OF ASSORTMENT OF MEDICATIONS FOR THE TREATMENT OF ATOPIC DERMATITISMARKETING ANALYSIS OF ASSORTMENT OF MEDICATIONS FOR THE TREATMENT OF ATOPIC DERMATITISGerasimovaOlga V.GerasimovaOlga V.BelousovaOlga V.BelousovaOlga V.belousovaov31@mail.ruBelousovYevgeny A.BelousovYevgeny A.20162300

Currently, there is an increasing number of people suffering from allergic diseases worldwide. One of the most common allergic diseases is atopic dermatitis characterized by a phasic course, the clinical polymorphism and the progression of pathological changes in the systems of the human body. The aim of this study was to analyze the range of medicines used for the treatment of atopic dermatitis. The objects of research were five pharmacies of the pharmacy network "Tabletochka", the price lists of firms-distributors of the Belgorod pharmaceutical market. Methods used in the work: structural, graphical, analytical, content analysis. As a result of the marketing research there was determined the structure of the assortment of medicines (drugs) for the treatment of atopic dermatitis both in the regional market and in the pharmacy. The authors allocated the basis of the range according to the ATC-classification, produced an intragroup analysis of the assortment structure and consumption of drugs in accordance with manufacturing characteristics and dosage forms. The obtained knowledge about the range of drugs used for the treatment of atopic dermatitis will optimize the number of items to avoid ordering unpopular drugs for the treatment of this disease and will improve the quality of pharmaceutical care.

Currently, there is an increasing number of people suffering from allergic diseases worldwide. One of the most common allergic diseases is atopic dermatitis characterized by a phasic course, the clinical polymorphism and the progression of pathological changes in the systems of the human body. The aim of this study was to analyze the range of medicines used for the treatment of atopic dermatitis. The objects of research were five pharmacies of the pharmacy network "Tabletochka", the price lists of firms-distributors of the Belgorod pharmaceutical market. Methods used in the work: structural, graphical, analytical, content analysis. As a result of the marketing research there was determined the structure of the assortment of medicines (drugs) for the treatment of atopic dermatitis both in the regional market and in the pharmacy. The authors allocated the basis of the range according to the ATC-classification, produced an intragroup analysis of the assortment structure and consumption of drugs in accordance with manufacturing characteristics and dosage forms. The obtained knowledge about the range of drugs used for the treatment of atopic dermatitis will optimize the number of items to avoid ordering unpopular drugs for the treatment of this disease and will improve the quality of pharmaceutical care.

marketing researchatopic dermatitisregional marketresistancerangethe ATC-classificationprovision of medicinesdermatologymarketing researchatopic dermatitisregional marketresistancerangethe ATC-classificationprovision of medicinesdermatologyСписок литературы1. Ado A.D. General Dermatology. M.: Medicine, 2010. 543 p. 2. Alekseev N.A., Alekseev M.N. Optimization of Provision of Medicines in the General Hospital on the Basis of Pharmaco-economic Analysis. Health Economics. 2007. N.1. Pp. 42-45. 3. Bezrukov D.A. The Epidemiology of Major Atopic Diseases: Bronchial Asthma, Atopic Dermatitis, Allergic Rhinitis. Astrakhan Medical Journal. 2009. N.3. Pp. 17-25.4. Veltischev Y.E. General Practitioner Handbook. 2008.Pp. 536-537.5. Dremova N.B. Marketing in Pharmacy: a Study Guide. Belgorod: Publishing House of BSU. 2010. 272 p.6. Ivanov O.L., Lvov A.N. The Dermatology Handbook. 2013. P.261-263.7. Klimov V.V. Clinical Immunology and Allergology. T., Printing Manufactory, 2008. Pp. 210-212.8. Lawlor G., Fischer T. Clinical Immunology and Allergology. M. "The Practice". 2012. Pp.  806-807.9. Sergeev Y. V. Atopic Dermatitis, 2005. Pp. 181-191.10. Factors influencing atopic dermatitis. Your dermatologist URL: http://www.dermatolog4you.ru/stat/derm_kosm/at_derm_fact_tech.html (date of access: December 23, 2015)11. Fiocchi A., Burks W., Bee Wah Lee Clinical Use of Probiotics in Pediatric Allergy (cuppa): A World Allergy Organization Position Paper. WAOJ. 2012. Vol. 5, № 11: 148-167.12. Follenweider, L.M., Lambertino A. Epidemiology of asthma in the United States / L.M. Follenweider,.  Nurs. Clin. North Am. 2013. Vol. 48: 1-10.13. Mexico City Childhood Asthma Study (MCAAS). Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations / D.G. Torgerson, E.J. Ampleford, G.Y. Chiu [et al.].  Nat. Genet. 2011. № 5: 887–892.14. Ober C., Moffatt M.F. Contributing factors to the pathobiology. The genetics of asthma / C. Ober,. Clin. Chest Med. 2000. № 5: 245–261.15. Reinholz T., Ruzicka D., Schauber J. Vitamin D and its role in allergic disease. Clin. Exp. Allergy. 2012. Vol. 42: 817-826.16. Tamari M., Tanaka S., Hirota T.  Genome-wide association studies of allergic diseases / M. Tamari, Allergol. Int. 2013. Vol. 62, № 1. P. 21- 2317. Vercelli, D. Gene-environment interaction sin asthma and allergy: the end of the beginning? Curr. Opin. Allergy Clin. Immunol. 2010. Vol. 10: 145-148.